NEW

GE HealthCare Preps for SIR 2024

GE HealthCare will showcase its latest technologies in image guiding solutions, surgery, ultrasound and CT-navigation at the upcoming 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting taking place March 23-28 in Salt Lake City, Utah. The...

Samsung Accepts Healthcare Innovator Award

Boston Imaging, the United States headquarters of Samsung’s digital radiography and ultrasound business, was awarded HHM Health’s Healthcare Innovator Award

AHRA Co-Founder Passes Away

On March 2, 2024, Louise Broadley passed away at 101 years old. AHRA shared the news via an email and website post that reads, “She was a noble woman, who not only achieved many milestones within the imaging profession, but likewise paved the way for aspiring leaders...

Artificial Intelligence Paper Outlines FDA’s Approach to Protect Public Health and Promote Ethical Innovation

Today, the U.S. Food and Drug Administration (FDA) released its “Artificial Intelligence and Medical Products: How CBER, CDER, CDRH, and OCP are Working Together,” which outlines how FDA’s medical product centers are working together to protect public health while...

Carestream Enables Reading of MR Perfusion, MR Diffusion Studies Directly From Vue PACS Diagnostic Viewer

Carestream Health has introduced new MR Brain Perfusion and MR Brain Diffusion modules that enable radiologists to read these imaging studies from a Carestream Vue PACS diagnostic viewer. The company has received FDA 510(k) Clearance for use in the United States, and these new tools also have been approved for use in Europe and other countries across the globe.

“Carestream is one of the first suppliers to support reading of both types of studies from the diagnostic viewer,” said Thierry Verstraete, Carestream’s Worldwide Product Manager for Clinical Solutions & Analytics. “Other companies require viewing on dedicated workstations with 3D post-processing software, which limits access and can delay diagnosis and treatment.”

Carestream’s MR Perfusion and MR Diffusion modules successfully completed clinical evaluation at a prominent French hospital.

“The Carestream software was simple to use and Carestream’s modules showed better consistency of perfusion and diffusion maps and results than our existing software. This new software will be very useful in making clinical decisions for treating acute stroke and lesions,” said Dr. Daniel Reizine, Neuroradiology, Hospital Lariboisière, Assistance Publique Hôpitaux de Paris, University Hospital of Île-de-France.

Carestream’s CT Brain Perfusion module provides interactive tools for analyzing tissue blood flow, tissue blood volume and capillary permeability. Blood perfusion parameters are automatically calculated and displayed as a set of user-friendly maps and tables that summarize the results.

Carestream’s MR Brain Perfusion module provides interactive tools for analyzing tissue blood flow, tissue blood volume and capillary permeability and delivers automatic generation of perfusion maps and a table of quantitative data that can be inserted into the radiology report.

Both CT and MR perfusion modules provide automatic identification of arterial input function, venous output function and brain centerline with the ability to edit and select additional vessels. Motion correction and ROI tools are available for improving diagnostic confidence.

Perfusion maps and quantitative measurements can be included automatically in the Vue Reporting module so this diagnostic information can be readily available to clinicians and referring physicians.

Carestream’s MR Brain Diffusion module provides interactive tools to ease analysis and comparison of MR diffusion-weighted images (DWI) and MR diffusion tensor imaging. The module is used to visualize local water diffusion properties from the analysis of diffusion-weighted MR data. Automatic display of DWI images as well as calculation of ADC maps can improve efficiency and diagnostic confidence.

Carestream’s Vue PACS lesion management tool enhances assessment of oncology patients with quantitative measurements, bookmarking and comparisons over time to aid oncologists who are making diagnostic and treatment decisions. It accepts prior exam results as baseline images from third-party PACS and from numerous modalities.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

Open